• About Us
    • What We Do
    • Our Story
    • Meet Our Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Careers
    • Australia
    • United States
  • Contact
  • About Us
    • What We Do
    • Our Story
    • Meet Our Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Careers
    • Australia
    • United States
  • Contact
Brisbane biotech company to send millions of COVID-19 tests to US

Brisbane biotech company to send millions of COVID-19 tests to US

Digital diagnostics company Ellume has already shipped the first batch from the initial order of 900,000 test kits to the US, and will bring online in October a larger facility at Richlands that has a capacity of 15 million units a month.
Read More
Experts push for faster coronavirus tests to help Australia adapt to a new ‘COVID-normal’

Experts push for faster coronavirus tests to help Australia adapt to a new ‘COVID-normal’

Queensland-based digital diagnostics company Ellume has developed an antibody test that gives a result in less than 15 minutes and has already sold 900,000 tests to the United States.
Read More
Antibody test lab has designs on going global

Antibody test lab has designs on going global

30 August 2020, Robyn Ironside This article originally appeared in The Australian, print and online, on 30th August 2020. View the original article here on The Australian website. A Brisbane laboratory anticipating huge global demand for COVID tests is building a facility capable of producing 15 million tests a month. Ellume Health has already received […]
Read More
World TB Day 2020

World TB Day 2020

#ItsTimeToEndTB: Diagnostics are critical in infectious disease control Written by Dr Sean Parsons, CEO Ellume. As the world rallies to curb the spread of COVID-19, this year’s World Tuberculosis Day serves as a stark reminder that the two major biological threats to humans are pandemic viruses (like COVID-19) and tuberculosis (TB) – especially multi-drug resistant […]
Read More
How Digital Diagnostics Are Changing Healthcare

How Digital Diagnostics Are Changing Healthcare

The Importance of Accurate Tests to Good Medicine – Despite advances in healthcare over recent decades, infectious diseases remain burdensome illnesses. Influenza kills more people in America than car accidents, tuberculosis kills over 5,000 people every day around the world, and antimicrobial resistance is a growing threat.
Read More
Ellume shines at AFR BOSS’ Most Innovative Companies Awards

Ellume shines at AFR BOSS’ Most Innovative Companies Awards

We’re excited to announce Ellume was recognised as one of Australia and New Zealand’s Most Innovative Companies in 2019, ranking #2 on the Health and Pharmaceutical list published by The Australian Financial Review and Boss Magazine. The prestigious annual list is based on a rigorous  assessment process managed by Australia’s leading innovation consultancy, Inventium, in […]
Read More
The 10 most innovative health companies

The 10 most innovative health companies

The AFR BOSS Most Innovative Companies list recognises the most innovative organisations in Australia and New Zealand, as judged by the expert panel assembled by The Australian Financial Review and Inventium.
Read More
From the emergency ward to pitching an IPO

From the emergency ward to pitching an IPO

Sean Parsons was a medical emergency doctor during the 2009 swine flu pandemic in Queensland when he decided to develop a home-test kit for the flu.
Read More
Flu-diagnostics startup Ellume raises $5 million as it gears up for IPO

Flu-diagnostics startup Ellume raises $5 million as it gears up for IPO

Brisbane Medtech startup Ellume has secured $5 million in funding for commercialising and developing its diagnostics products as it ramps up to listing on the ASX.
Read More
Ellume, the digital diagnostics company helping people beat the flu

Ellume, the digital diagnostics company helping people beat the flu

Dr Sean Parsons is the founder of Ellume, an emerging digital diagnostics company situated in Brisbane that provides smart, self-use diagnostics for the detection and management of pandemic influenza.
Read More
Page 3 of 41234
Recent Posts
  • Ellume founder Dr Parsons on COVID testing, Omicron
  • Ellume named Popular Science Best of What’s New 2021
  • Ellume wins AFR BOSS Most Innovative Company Award
  • QIAGEN receives U.S. FDA emergency use authorization for rapid portable SARS-CoV-2 antigen test
  • Push to allow at-home COVID tests in Australia
Archives
Categories
Business
Scroll
ellume logo white
Menu

Home
About Us
COVID-19 Response
Consumer Products
Professional Products
Global Public Health Solutions
Our Tech
News

Quick Links

Contact Us
Terms of Use
Privacy Policy
Whistleblower Policy

Some products pending regulatory clearance and not available for sale. © Ellume Limited 2022
ABN 13 141 767 660